AcuNetx's Balance Project Accepted by Pepperdine Business School

Business Wire, May 10, 2007

TORRANCE, Calif. -- AcuNetx (OTCBB:ANTX) announced today that its proprietary 'Balance Project' initiative will be the focus of Pepperdine University's Graziadio School of Business and Management's Summer Education to Business (E2B) Applied Learning Program. BusinessWeek ranks Pepperdine's MBA program first globally in Organizational Behavior and Management (http://bschool.pepperdine.edu).

The company's 'Balance Project' addresses a significant healthcare problem:

According to the NIH, balance problems are reported in about 9% of individuals who are 65 years of age or older, with fall-related injuries such as breaking (or fracturing) a hip being a leading cause of death and disability in older individuals. By 2020, the cost of fall injuries in this age group is projected to reach nearly $33 billion.

Speaking for AcuNetx, CEO Ron Waldorf commented, "Working with the world-class Graziadio School is a great opportunity to understand the commercial potential resulting from lessening these patients' potential to fall and increasing their quality of life with our proprietary products and services."

Michael Lesner will head-up the 'Balance Project' for AcuNetx. Lesner's medical marketing background includes the first home health magazine with Surgeon General Charles Everett Koop; co-authoring the Kidney Dialysis Guide (a joint venture between Amgen and HCFA); branding Baxter's Operating Room Division; creating McKesson HBOC's ePharmacy initiative; and developing VisMed[TM], a key medical software program which is today used in over 30 major hospital systems.

"Working with organizations such as AcuNetx provides our MBA students with hands-on, experiential learning. The students have been charged with analyzing the market opportunity for the company's new healthcare offering and determining the best method for commercialization," said Doreen Shanahan, director of the Graziadio School's Education to Business program.

About AcuNetx, Inc.:

AcuNetx markets a diverse line of diagnostic, analytical and therapeutic tools to audiologist, neurologists, otolaryngologists and physical therapists as well as hospitals, clinics, and extended care facilities. AcuNetx is headquartered in Torrance, CA. For more information concerning AcuNetx and its subsidiaries, please visit www.acunetx.com

Safe Harbor for Forward-Looking Statements:

This news release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.